Marketing-authorisation holder
5 medicines in 1 country, as authorisation holder and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AZUL PATENTE AZULTIS 25 MG/ML SOLUCION INYECTABLE EFG25 mg/ml · Solución inyectable | Azul patente v | Spain | Authorised | 2025 |
| CLORURO DE METILTIONINIO PROVEBLUE 5 MG/ML SOLUCION INYECTABLE5 mg · Solución inyectable | Methylthioninium chloride | Spain | Marketed | 2018 |
| Cloruro de metiltioninio Proveblue 5 mg/ml solucion inyectable50 mg · Solución inyectable | Methylthioninium chloride | Spain | Marketed | 2013 |
| PROVINGO 40 MG/5 ML SOLUCION INYECTABLE8 mg/ml · Solución inyectable | Indigo carmine | Spain | Authorised | 2025 |
| SUGAMMADEX PROVEPHARM 100 MG/ML SOLUCION INYECTABLE EFG108,8 mg/ml · Solución inyectable | Sugammadex | Spain | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 5 | 5 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Keep Provepharm’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call
